Deep breaths for better sleep: simple breathing therapy tested in schizophrenia
NCT ID NCT07150507
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tested whether a structured breathing therapy program could reduce sleep problems and fatigue in people with schizophrenia. Sixty-eight patients took part, with one group receiving eight sessions of breathing therapy while the other group received no extra care. Researchers measured changes using sleep and fatigue scales. The goal was to see if this simple, drug-free approach could improve daily well-being.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- breathing therapy
- What this could lead to
- If it works, this could offer a simple, non-drug way to help people with schizophrenia sleep better and feel less tired.
- What could go wrong
- This is a small, single-site study with no blinding or placebo control, so results may not be reliable or apply to others. The therapy only targets symptoms, not the illness itself.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
68 people
The number who actually took part.
- Started
-
Apr 2022
- Finished
-
May 2023
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 60 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Being registered with a CMHC * Being diagnosed with schizophrenia * Being between the ages of 18 and 60 * Being willing to participate in the study * Being open to communication and cooperation * Being in remission Exclusion Criteria: * Not being open to communication and cooperation
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Breathing therapy are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Ataturk University Faculty of Nursing
Erzurum, Yakutiye, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Your voice may reveal if You're taking your psychiatric medication
- Scientists probe brain's reward system in mental illness
- New schizophrenia drug targets brain glutamate, not dopamine
- New drug candidate takes aim at schizophrenia symptoms
- New schizophrenia drug goes Head-to-Head with standard antipsychotics in Long-Term trial
- Five-Year safety check for experimental schizophrenia drug